VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P29
Within normal range
vs 3Y Ago
-30.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-54.32%
2024568.72%
2023-120.47%
20221.78%
20210.00%
20200.00%
20190.00%
2018-100.00%
20170.00%
20160.00%